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Background
The results of the RV144 trial support the ability of vac-
cine induced Antibodies to protect from HIV acquisition.
The STEP trial also appears to have impacted viral load in
individuals who produced strong T cell immunity. The
HVTN has recently reported that our enhanced DNA
(Pennvax) can drive T cell immunity as robust as Adeno-
viral and Pox platforms in an accelerated format in
humans. We have now focused on further driving T and B
cell immunity by utilizing prime boost
Methods
Groups of rabbits or Indian Rhesus macaques were vacci-
nated with enhanced DNA vaccine plasmids encoding
pGAG, pPOL + combinations of 3-5 consensus or COT
designed envelopes that were either gp140 or gp160 con-
structs. Both IM as well as a novel minimally invasive skin
delivery EP arrays (MID) were studied. DNA vaccinated
animals were boosted two months following the final
DNA immunization with SF162 gp120 in MF59.
Results
In rabbits, nAb titers against a broad panel of Tier 1
viruses was observed by the combination immunization
approaches. Titers in the hundreds were induced by DNA
and these titers were enhanced almost a log by a protein
boost. Similar data was also observed when these studies
were extended to the non-human primate model. Impor-
tantly, DNA-prime protein-boost had detectable ADCC
activity as measured by the GTL and luciferase assay. A
bias for improved antibody responses driven by the MID
delivery array is also observed.
Conclusion
Building on the success observed in HVTN 080 we report
that further enhancement of DNA constructs in a prime
boost setting (E-DNA prime + protein Boost) is capable of
eliciting high binding, broad antibody responses and neu-
tralization titers against a panel of tier 1 viruses. Combin-
ing improved E-DNA with other strategies shown to
enhance antibody responses such new gene adjuvants are
being investigated.
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